Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.
Lucy Jung is the CEO and founder at Charco Neurotech, a medtech start-up which has developed the CEU1, a wearable device for Parkinson's, that uses vibrotactile stimulation to reduce symptoms of slowness and stiffness - resulting in improved movement....
The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.
A study out of Israel's Sheba Medical Center found wearables used to monitor patients can provide early warnings of deterioration, as well as false alarms.
In this second of a two-part series, a leader from the CRO discusses the types of technologies supporting DCTs and what might lie on the horizon for the field.
Electronic health record solutions provider Athenahealth has partnered with Withings Health Solutions to put the RPM tech into place for clinical and care use.
Withings Health Solutions' new remote patient monitoring (RPM) system seeks to tackle complexities identified after the launch of its first offering in the space.
A study conducted by trial tech firms Curedatis and Climedo Health reveals what trial professionals view as challenges and opportunities in digitalization.
The medical device tech firm is poised to assist manufacturers in navigating the new European Medical Device Regulation, which goes into effect this week.
A leader from digital health solutions firm CitiusTech suggests use of fast healthcare interoperability resources is useful in the face of evolving tech.
The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants.
The technology is designed to streamline and simplify integration, data collection and analysis, and digital biomarker discovery with wearable sensors.
The trials, funded by the American Heart Association, will harness the company’s Verisense wearable sensor platform to examine brain-heart health links.
The Medical Data Platform, an RPM solution from VivaLNK, handles clinical trials, cardiac monitoring, remote and in-patient monitoring and other tasks.
The research (conducted by trial tech provider Litmus Health) shows an indepth picture of wearable device use, top devices, data capture and other factors.
OSP's free Digital Advances in Clinical Trial webinar (on December 9) will feature experts discussing recent advancements in the rapidly evolving field.
Taking place December 9, the Digital Advances in Clinical Trials webinar covers notable advances in clinical trial technology, and the future of the field.
With the Open Wearables initiative, Shimmer Research is looking to bring research professionals together on solutions for the common good of the industry.
Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemic’s effects.
Shimmer Research launches an initiative to develop a set of open-source algorithms and software tools for analyzing wearable sensor data – and, ultimately, standards that will be accepted by industry and regulators.
After ‘holding its breath’ for nearly half a decade, pharma and health care companies are ready to implement new technology in clinical trials – though data standardization will be key to fully realizing the benefits.
As the industry focuses on modernizing clinical research, Thread is set to continue expanding its virtual research platform after today announcing its acquisition by strategic investors, says company executive.
HCL Technologies and Oracle Health Sciences announce a collaboration to “bridge the gap” between the potential of mobile health and the realities of adoption, says EVP.
At a time when innovation is rapid, clinical development is evolving at the same pace, and new technologies are bringing disruptive opportunities to research, says AbbVie executive.
It’s a lot more complicated than a simple technology – says Iqvia global head of virtual trials, who shares four lessons learned during a discussion at the company’s headquarters in Research Triangle Park.
Litmus Health today released a new version of its end-to-end real-world data platform for clinical research – as the industry increasingly adopts wearable technology to monitor patients in their homes, says CMO.
A study by Biofourmis aims to improve patient centricity in the drug approval processes by using wearable technology and mobile software to monitor the quality of life for patients with heart failure.
MIT has developed an ‘invisible’ device that provides several benefits over traditional patient data collection methods, including improved biomarker development and the ability to detect changes in behavior – by monitoring patients wirelessly, and through...
More than half of new drug approvals last year were for rare diseases – which face long cycle times and other operational challenges that are necessitating the rapid adoption of new solutions, per a recent Tufts report.
Sponsors to benefit from more accurate, shorter, and less costly trials through Shimmer Research and ClearSky Medical Diagnostics partnerships, says company executive.
Live updates from the DIA Global Annual Meeting 2019 in San Diego as industry leaders from over 50 countries and 400 companies discuss the progress and innovations in drug product development.
New this year to the discussion at DIA is the conversation around data ownership, as the industry continues to face a deluge of information from more sources than ever.
Medable has received $3.5m to further develop its end-to-end platform for digitally-enabled clinical trials, which can be used at an individual, study, or population level.
VivaLNK’s wearable sensor platform – currently being used in a clinical trial to remotely monitor patients – integrates hardware, connectivity, and application software, taking an "uncommon" approach in the medical technology space, says CEO.
Drug development – a dynamic and evolving process – is modernizing at an unprecedented rate, says industry expert, who stresses that change must continue to fully explore the opportunities.
Bridging the gap between clinical care and research means creating two-way collaboration, improving the way in which data is collected, organized, shared – and engaging EHR vendors, says conference panelist.
Artificial intelligence advances threaten data privacy, according to a new study, which found it is possible to re-identify individuals using their physical activity data.
Shimmer designed its new Verisense platform from the ground up after finding that current activity trackers fail to meet the “basic needs of the clinical research market,” says company executive.
monARC Bionetworks’ Smart Health Record allows patients to directly share with researchers their data from various disparate sources – “creating a new data collaboration economy.”
The All of Us research program is expanding its data collection abilities via Fitbit – a move that further demonstrates the industry’s increasing adoption of a BYOD approach, says Thread executive.
The EMA recently outlined five strategic goals with a focus on fostering clinical trial innovation, optimizing capabilities in modeling and simulation, as well as exploiting AI and investing in special populations, among other objectives.
